Clinical Research Directory

Inclusion Criteria: * Individuals with moderate to severe skin dryness as assessed by a clinician (ODS score of 2 or 3) * Individuals with moderate to severe self-reported skin itching as assessed by a clinician (NRS ≥ 1) * Individuals aged 55 years and older * Open to patients with one or more of the following conditions: 1. History of atopic dermatitis; 2. Currently using a stable medication regimen prescribed and monitored by a physician (ongoing use), where the medication has side effects causing skin dryness (e.g., statins, calcium channel blockers, diuretics, antiplatelet agents, ACE inhibitors, beta-blockers, adrenergic receptor agonists, immunosuppressants, etc.); 3. Patients with systemic diseases associated with dryness (diagnosed and managed by a physician), such as diabetes, hyperthyroidism, hypothyroidism, or hemodialysis. * Voluntarily participate in the trial, understand and agree to sign the informed consent form, and agree to follow the study protocol throughout the study period, including using the study-provided products, not using other similar products, completing a diary, and attending regular follow-up visits as required by the trial. Exclusion Criteria: * Individuals with a history of allergy, allergic reaction, or hypersensitivity to any component of the study product (Cerave Neuroceramide Moisturizing Repair Body Lotion); * Individuals with a history of allergic contact dermatitis secondary to the use of moisturizing products; * Individuals with any clinical manifestations or other conditions at the treatment site that the physician deems may affect the evaluation or results of the study product; * Individuals who are unable or unwilling to attend all study visits and adhere to the treatment regimen; * Individuals who have participated in any other drug clinical studies within the past 3 months prior to the start of the trial.